z-logo
Premium
MYPT1 isoform expression is regulated by p42/44 signaling
Author(s) -
Brozovich Nikolas J,
Hawes Grescin,
Yuen Samantha,
Ogut Ozgur,
Brozovich Frank V
Publication year - 2012
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.26.1_supplement.870.3
Subject(s) - myosin light chain phosphatase , mapk/erk pathway , microbiology and biotechnology , phosphatase , phosphorylation , protein phosphatase 1 , myosin light chain kinase , signal transduction , downregulation and upregulation , myosin , stimulation , chemistry , biology , endocrinology , biochemistry , gene
During NO mediated vasodilatation, PKG activates myosin light chain (MLC) phosphatase to reduce MLC phosphorylation and force. MLC phosphatase is a trimeric enzyme consisting of a catalytic, myosin targeting (MYPT1) and 20 kDa subunits. Alternative mRNA splicing produces four MYPT1 isoforms, which differ by the presence or absence of central insert (CI) and a carboxy‐terminal luecine zipper (LZ). PKG mediated activation of MLC phosphatase requires the expression of a LZ+ MYPT1 isoform, and during heart failure, there is an activation of p42/44 MAPK signaling and a decrease in LZ+ MYPT1 expression. We examined p42/44 MAPK signaling and LZ+ MYPT1 expression during angiotensin II (AngII) stimulation of cultured smooth muscle cells (SMCs). AngII resulted in a time dependent activation of p42/44 MAPK and a decrease in LZ+ MYPT1 expression. However pretreatment of the SMCs with a MEK inhibitor (PD98059) blocked the AngII induced activation of p42/44 MAPK and decrease of LZ+ MYPT1 expression. These results demonstrate that LZ+ MYPT1 expression is regulated by a p42/44 MAPK signaling pathway. During heart failure, treatment with either ACE inhibitors or AngII receptor blockers will prevent the activation of p42/44 MAPK and the resulting decrease in LZ+ MYPT1 expression to preserve the sensitivity of vascular smooth muscle to NO mediated vasodilatation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here